YEAR
- 2011.10.23 Suppression of bone formation by osteoclastic expression of semaphorin 4D. Negishi-Koga T, Shinohara M, Komatsu N, Bito H, Kodama T, Friedel RH, Takayanagi H.Nat. Med. 2011 Oct 23;17(11):1473-80. doi: 10.1038/nm.2489
- 2011.10.09 Structural basis for the bifunctionality of fructose-1,6-bisphosphate aldolase/phosphatase Fushinobu S, Nishimasu H, Hattori D, Song HJ, Wakagi T.Nature. 2011 Oct 09;478(7370):538-41. doi: 10.1038/nature10457
- 2011.03.01 Stable knockdown of S100A4 suppresses cell migration and metastasis of osteosarcoma. Fujiwara M, Kashima TG, Kunita A, Kii I, Komura D, Grigoriadis AE, Kudo A, Aburatani H, Fukayama M.Tumour Biol. 2011 Jun;32(3):611-22. doi: 10.1007/s13277-011-0160-y
- 2011.01.06 RACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3K/Akt pathway. Wang F, Yamauchi M, Muramatsu M, Osawa T, Tsuchida R, Shibuya M.J. Biol. Chem. 2011 Mar 18;286(11):9097-106. doi: 10.1074/jbc.M110.165605
- 2011.09.03 Preferential expression of potential markers for cancer stem cells in large cell neuroendocrine carcinoma of the lung. An FFPE proteomic study. Nomura M, Fukuda T, Fujii K, Kawamura T, Tojo H, Kihara M, Bando Y, Gazdar AF, Tsuboi M, Oshiro H, Nagao T, Ohira T, Ikeda N, Gotoh N, Kato H, Marko-Varga G, Nishimura T.J Clin Bioinforma. 2011 Sep 03;1(1):23. doi: 10.1186/2043-9113-1-23
- 2011.12.05 Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy. Hayashi T, Horiuchi A, Sano K, Hiraoka N, Kasai M, Ichimura T, Sudo T, Tagawa Y, Nishimura R, Ishiko O, Kanai Y, Yaegashi N, Aburatani H, Shiozawa T, Konishi I.Sci Rep. 2011;1:180. doi: 10.1038/srep00180
- 2011.11.17 Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis. Tsuji S, Midorikawa Y, Takahashi T, Yagi K, Takayama T, Yoshida K, Sugiyama Y, Aburatani H.Br. J. Cancer. 2012 Jan 03;106(1):126-32. doi: 10.1038/bjc.2011.505
- 2011.03.16 Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery: epigenetic regulation of the hypoxic response via hypoxia-inducible factor and histone modifying enzymes. Mimura I, Tanaka T, Wada Y, Kodama T, Nangaku M.J. Pharmacol. Sci. 2011;115(4):453-8. doi: 10.1254/jphs.10r19fm
CLOSE